LOM Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Buy
2,215
+54
+2% +$55.2K 0.69% 46
2026
Q1
$1.99M Buy
2,161
+33
+2% +$33.5K 0.57% 65
2025
Q4
$2.29M Buy
2,128
+12
+0.6% +$11.5K 0.66% 49
2025
Q3
$1.61M Buy
2,116
+728
+52% +$542K 0.49% 70
2025
Q2
$1.08M Buy
+1,388
New +$1.08M 0.37% 84

Other funds holding LLY

LOM Asset Management's LLY Position: Q2 2026 in Review

LOM Asset Management increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $55.2K and bringing the position to 2,215 shares worth $2.66M. The position accounts for 0.69% of the portfolio, ranked #46.

LOM Asset Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LOM Asset Management held 2,215 shares of Eli Lilly worth $2.66M as of Q2 2026.
  • LOM Asset Management bought 54 Eli Lilly shares in Q2 2026, an estimated $55.2K.
  • Eli Lilly made up 0.69% of LOM Asset Management's portfolio in Q2 2026, its #46 holding.
  • LOM Asset Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LOM Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.